MedPath

Schema Therapy for Couples (ST-C) with (one or both having) a Personality Disorder: a pilot study.

Conditions
ot applicable
Registration Number
NL-OMON24101
Lead Sponsor
PsyQ Amsterdam (Parnassia Group)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
12
Inclusion Criteria

Personality Disorder according to the criteria of the DSM-5 and as measured using
the SCID-5-P
-Age 18+
-Ability to understand, read, write and speak Dutch or English

Exclusion Criteria

-DSM-5 alcohol or drug dependence. (After 3 months of abstinence participation is possible).
-Comorbid psychotic disorder
-DSM-5 Bipolar disorder, type 1 (current or past)
-Schizo-typical-, Schizoid-, Anti-social PD
-Borderline personality disorder patient and or partner
-Autism Spectre Disturbance (ASD)
-Acute relationship crisis with acute threat of divorce or splitting up
-Acute suicide risk
-Born with brain damage
-Degenerative cognitive disturbances like Alzheimer, Parkinson etc.
-IQ < 80
-Schema Therapy of any kind (e.g., individual, group, inpatient, outpatient, day treatment) in the past year.
-Patients or their partners should not start with any form of psychological treatment or medication during screening or during the study’s treatment, waitinglist period or till a year after end of last boostersession. Medication should be on a stable level for 3 months, if not stopped. (in case patient and or his partner receives non-PD focused supportive treatment, this can be continued during the waiting period, but not during the study treatment).
-Not being able to plan therapy sessions of 60 minutes (ST-C, boostersessions and communication training sessions) and/or 45 minutes (ST-I) within the treatment period.
-Moving house plans to outside the agglomeration of Amsterdam.
-Partner has PD and wants only to participate in ST-C, refuses to participate in ST-I.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome will be measured with the Visual Analog Scale (VAS). With the VAS negative (core) beliefs partners have about themselves and each other will be measured on a weekly basis. This will lead to two scores: the average score on negative self beliefs and an average score on negative beliefs about the other.
Secondary Outcome Measures
NameTimeMethod
The following scales will be used to measure the secondary outcomes. The ARE (Accessibility, Responsiveness, Emotional Engagement, Conradi et al., 2018) questionnaire measures the security of the attachment bond with the partner. With the Daily Coordination Scale (DC, Finkenauer et al. 2010) one measures the degree to which partners experience their daily interactions as smooth or as difficult.
© Copyright 2025. All Rights Reserved by MedPath